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Abstract 
Introduction: Staphylococcus aureus produces a variety of diseases among children, ranging from skin and soft tissue infections to invasive 
life-threatening diseases. Since 1990, an increasing number of diseases produced by community-associated methicillin-resistant S. aureus 
(CA-MRSA) isolates have been reported. The aim of this study was to describe the importance and the microbiological characteristics of S. 
aureus isolates recovered from children treated at the Hospital Pediátrico del Centro Hospitalario “Pereira Rossell” (HP-CHPR); focusing on 
invasive diseases caused by CA-MRSA isolates, as well as some clinical aspects of the diseases they have produced. 
Methodology: One hundred and twenty-five S. aureus isolates recovered from the HP-CHPR between 2003 and 2006 from children with 
invasive (n=89) and superficial diseases (n=36) were included. Genotypic and phenotypic characteristics of S. aureus isolates and relevant 
clinical aspects of each child were studied. 
Results: CA-MRSA isolates accounted for 73% of all S. aureus recovered from invasive (mainly bone and joint) infections, pneumonia and 
bacteraemia. The most common CA-MRSA strain recovered from invasive (n=65) and superficial (n=36) diseases had the following features: 
pulsotype A (type USA1100), SCCmec cassette type IV, Panton-Valentine Leukocidin genes positive, susceptibility to trimethoprim-
sulfamethoxazole without the inducible macrolide-lincosamide-streptogramin B (iMLSB) resistance phenotype. No association between 
genotypic characteristics of invasive CA-MRSA isolates and clinical outcomes was found. 
Conclusions: CA-MRSA isolates produced a wide spectrum of invasive diseases in a public paediatric hospital between 2003 and 2006. 
Microbiologic characterization suggests the spread of an adapted CA-MRSA clone lacking erm genes. 
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Introduction 
Staphylococcus aureus produces a variety of 
diseases among children, ranging from skin and soft 
tissue infections (SSTIs) to invasive life-threatening 
diseases [1-3]. An important characteristic of S. aureus 
is its capacity to acquire resistance to antibiotics, 
making it difficult to choose a suitable empiric 
antimicrobial therapy. Since 1990, an increasing 
number of diseases produced by methicillin-resistant 
S. aureus (MRSA) have been reported, affecting 
individuals without the classic risk factors linked to  
the acquisition of health-care associated methicillin-
resistant S. aureus (HA-MRSA) strains [1,4-6]. These 
strains are now known as community-associated 
methicillin-resistant S. aureus (CA-MRSA) in contrast 
to HA-MRSA. CA-MRSA isolates are often only 
resistant to methicillin; they harbor SSCmec types IV, 
V or VII and most of them carry lukS-F genes [4]. 
In recent years, there has been a marked increase 
in the rate of CA-MRSA infections among children 
and adults [7,8] in Uruguay. According to data from 
the Pediátrico del Centro Hospitalario “Pereira 
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Rossell” (HP-CHPR) hospital 2% of S. aureus isolates 
recovered in 2001 were MRSA; in 2003 they 
accounted for 35%, and the figure rose to more than 
50% in 2004. 
The aim of this study was to describe the 
importance and the microbiological characteristics of 
S. aureus isolates recovered from children treated at 
the HP-CHPR; focusing on invasive diseases caused 
by CA-MRSA isolates, as well as some clinical 
aspects of the diseases they produce. 
 
Methodology 
Setting 
The HP-CHPR is a 300-bed tertiary reference 
centre for all medical and surgical pediatric specialties.  
It provides high-level annual care to more than 
300,000 children under 15 years old. Children 
receiving medical care at the HP-CHPR often come 
from low-income households. 
 
Children and bacterial isolates 
We analyzed 125 S. aureus isolates recovered 
between January 2003 and October 2006 from 125 
children who sought medical attention at the HP-
CHPR. Isolates obtained from children younger than 
28 days old and those from children over the age of 15 
years were excluded from the study. All S. aureus 
isolates (n = 89) recovered from invasive infections 
(e.g., bone, blood, cerebrospinal, pleural, and synovial 
samples) and 36 randomly selected MRSA isolates 
recovered in the same period from children with 
superficial infections, were also included in this study. 
Clinical information of each child such as age, gender, 
site of infection, admission to intensive care unit 
(ICU), and outcome were obtained from medical 
records.  
 
Isolate identification and antimicrobial susceptibility 
testing 
S. aureus isolates were identified by standard 
phenotypic procedures (colony morphology, Gram 
stain, catalase test, DNase activity, presence of 
clumping factor, and protein A by the latex 
agglutination test). MRSA strains were defined as CA-
MRSA when they met the following criteria: they 
harboured SCCmec type IV, V or VI and were either 
susceptible to all non-beta-lactam antibiotics, showed 
resistance only to erythromycin, or displayed the 
inducible macrolide-lincosamide-streptogramin B 
(iMLSB) phenotype; they were isolated within 48 
hours of admission to the  HP-CHPR; and they were 
isolated from a child who had no previous history of 
hospitalization, surgery, dialysis or residence in a 
long-term care facility within one year of the MRSA 
culture date, or who had no permanent in-dwelling 
catheter or percutaneous medical device and no known 
prior positive culture for MRSA. Isolates were defined 
as HA-MRSA when they carried SCCmec type I, II or 
III, displayed a multiple antibiotic resistance profile, 
and they were isolated from a child who presented 
with any of the risk factors described above [4]. 
Antimicrobial susceptibility was determined using 
the disk-diffusion method, following 
recommendations from the Clinical and Laboratory 
Standards Institute [9]. The antibiotics tested were 
oxacillin (OXA), gentamicin (GM), 
trimethoprim/sulfamethoxazole (TMP-SMX), 
erythromycin (ERY), and clindamycin (CLI) (Oxoid 
Ltd., Basingstoke, Hampshire, UK). S. aureus strain 
ATCC 25923 was used for quality control. A double 
disk diffusion test was performed to determine the 
iMLSB phenotype [9]. The presence of PBP2a protein 
in MRSA isolates was determined by commercial 
latex agglutination test (Oxoid). 
S. aureus isolates were stored in skimmed milk 
frozen at -20ºC and sent to the Department of 
Bacteriology and Virology of the School of Medicine, 
Universidad de la República, for genotyping. 
 
Genotyping  
Bacterial DNA was obtained from isolated 
colonies using the Wizard genomic DNA preparation 
kit (Promega, Madison, WI, USA) using 20 mg/mL 
lysostaphin (Sigma-Aldrich, St. Louis, MO, USA) in 
the cell-lysis step [10]. The presence of collagen-
binding adhesin (cna) and Panton-Valentine 
Leukocidin (PVL) lukS-F genes was determined by 
PCR according to previously described procedures 
[11,12]. The SCCmec cassette type and presence of the 
mecA gene were determined by a multiplex PCR [13, 
14]. 
DNA macrorestriction and separation of fragments 
by pulsed field gel electrophoresis (PFGE) were 
completed using a standardized protocol for the 125 S. 
aureus isolates [15]. DNA was digested with SmaI 
(New England Biolabs, Beverly, MA, USA) and 
PFGE conditions were 6 V/cm at 11.3°C for 23 hours 
with pulses ranging from 5 to 35 seconds. 
Electrophoresis was performed using a CHEF DR II 
instrument (Bio-Rad, Hercules, CA, USA). Band 
patterns were visually interpreted according to 
previously published criteria [16]. 
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Multilocus sequence typing (MLST) 
Multilocus sequence typing (MLST) was 
performed on two randomly selected CA-MRSA 
strains belonging to pulsotype A, as previously 
published by Enright et al. [17]. PCR products were 
sequenced at the Instituto Pasteur de Montevideo 
(Montevideo, Uruguay) and the obtained sequences 
were analyzed using MLST website 
(http://www.mlst.net). 
 
Statistical analysis 
Fischer’s exact test was used to investigate a 
possible association between the presence of virulence 
factors and outcome of invasive diseases. A P value < 
0.05 was considered statistically significant. 
 
Results 
Microbiological characteristics of S. aureus isolates 
recovered from invasive infections 
Out of 89 S. aureus isolates recovered from 
children with invasive infections, 21 (23.6%) were 
susceptible to oxacillin (MSSA) while 68 (76.4%) 
were resistant (MRSA) (Table 1). All MRSA isolates 
expressed a PBP2a protein and carried the mecA gene. 
Three of the sixty-eight (4.4%) MRSA isolates 
were defined as HA-MRSA. One HA-MRSA isolate 
was susceptible to TMP-SMX, carried SCCmec type I, 
and visually its PFGE profile closely resembled the 
previously described MRSA “Cordobes clone” (Figure 
1, lane 3) [18]. The other two isolates were resistant to 
TMP-SMX; both carried SCCmec type III and showed 
a different PFGE profile (Figure 1, lanes 1 and 2). The 
remaining 65 MRSA isolates were defined as CA-
MRSA (Table 1) and 29 (44.6%) showed an iMLSB 
phenotype. All 65 CA-MRSA isolates carried SCCmec 
type IV; 52 isolates displayed PFGE pulsotype A 
(PFGE profile type USA1100) (Figure 1, lane 8); and 
isolates 55 and 57 contained lukS-F and cna genes, 
respectively (Table 2). Both CA-MRSA isolates 
analyzed by MLST belonged to ST30. 
Four out of 21 MSSA isolates recovered from 
invasive infections were resistant to ERY, GM or CLI 
but none showed the iMLSB phenotype. Six isolates 
were positive for the lukS-F genes (Table 2). 
Pulsotype D (Figure 1, lanes 6 and 7) was most 
frequently found in MSSA isolates (n = 9; there were 4 
pulsotype A; and 2 pulsotype C isolates as well). All 
remaining MSSA isolates showed different PFGE 
profiles that did not match any previously observed 
profile in this study. 
Table 1. Invasive S. aureus isolates recovered from children treated at the HP-CHPR between 2003 and 2006 
 
 MRSA   MSSA  
 
Infection site 
No. of CA-MRSA 
Isolates 
a
 
No. of HA-MRSA 
Isolates 
a
 
 No. of MSSA 
Isolates 
 
TOTAL 
Bone and Joint infections 29 2  13 44 
Bacteraemia 14 0  7 21 
Pneumonia 19 0  1 20 
CNS 2 0  0 2 
Catheter infection 0 1  0 1 
Endocarditis 1 0  0 1 
TOTAL 65
 3  21 89 
a The criteria used to distinguish between CA-MRSA and HA-MRSA isolates are included in the text [4]. 
 
Figure 1. Representative PFGE profiles of Staphylococcus 
aureus isolates recovered from children treated at the HP-
CHPR between 2003 and 2006  
 
Lane 1 and 2: HA-MRSA isolates resistant to TMP-SMX; lane 3: 
HA-MRSA isolate susceptible to TMP-SXM (PFGE profile type 
“Cordobes clone”); lane 4: S. aureus NCTC 8325; lane 5: CA-
MRSA isolate recovered from a superficial infection (PFGE profile 
type USA1100); lane 6 and 7: MSSA isolates recovered from 
invasive infections; lane 8: CA-MRSA recovered from invasive 
infection (PFGE profile type USA1100) 
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Microbiological characteristics of MRSA isolates 
recovered from superficial infections 
All MRSA isolates (n = 36) recovered from 
superficial infections were identified as CA-MRSA 
and carried the type IV SCCmec cassette. Of the 36 
isolates, 29 and 30 carried the lukS-F and cna genes, 
respectively (Table 2). Twenty-nine strains 
corresponded to pulsotype A (PFGE profile type 
USA1100) (Figure 1, lane 5). 
Overall, 40 out of 101 CA-MRSA isolates 
(invasive n = 29 and superficial n = 11) displayed the 
iMLSB phenotype (Table 2). Figure 2 shows the 
distribution of these 40 isolates over the years of 
isolation. 
 
Clinical aspects of infection and their association with 
S. aureus microbiological characteristics 
The median age of children included in the study 
was 63 months (5.25 years old); 59% were male. Bone 
and joint infections accounted for 50% of invasive 
disease (n = 44), followed by bacteraemia 23.5% (n = 
21) and pneumonia 22.4% (n = 20). CA-MRSA 
isolates were recovered from bone and joint infections 
(n=29, 66%); bacteraemia (n = 14, 67%); pneumonia 
(n = 19, 95%); central nervous system infections (n = 
2) and endocarditis (n = 1) (Table 1). Twenty-three of 
the 65 children with CA-MRSA invasive infection 
were admitted to the ICU.  Nineteen of the CA-MRSA 
isolates recovered from these children belonged to 
pulsotype A (USA1100) and 19 isolates also carried 
lukS-F and cna genes (Table 3). 
Over one-third (8 of 23; 34.7%) of the children 
admitted to the ICU died. Clinical diagnosis of the 
deceased children was sepsis (n = 3), pneumonia with 
empyema (n = 3), and bone and joint infection (n = 2). 
Isolates 6 and 7 recovered from these children carried 
the lukS-F and cna genes, respectively. No deaths 
were reported in the remaining 42 children with CA-
MRSA invasive infections not admitted to the ICU 
(Table 3). No children with invasive infections caused 
by MSSA isolates (n = 21) or HA-MRSA isolates (n = 
3) were admitted to ICU and no deaths were reported 
in this group (Table 1). 
No children with superficial infection (n = 36) 
were admitted to the ICU and no associated deaths 
were registered in this group. CA-MRSA isolates were 
recovered from abscesses (n = 20), cellulitis (n = 6), 
and other superficial skin infections (n = 10). Thirty  
 
Table 2. Microbiological characteristics of 125 S. aureus isolates recovered from children with invasive and superficial infections treated 
at the HP-CHPR between 2003 and 2006 
 CA-MRSA  HA-MRSA  MSSA 
 
Genotypic or phenotypic 
characteristic 
Invasive (n=65) 
Nº. (%) of isolates with 
positive result to: 
Superficial (n=36) 
Nº. (%) of isolates with 
positive result to: 
 
Invasive (n=3) 
Nº.  of isolates with 
positive result to: 
 
Invasive (n=21) 
Nº. (%) of isolates with 
positive result to: 
       
LukS-F genes 57 (87.6) 30 (83.3)  0  6 (28.5) 
cna gene 55 (84.6) 29 (80.5)  1  3 (14.2) 
SCCmec cassette type IV 65 (100) 36 (100)  0 a  NAb 
Pulsotype A (USA1100) 52 (80) 29 (80.5)  0  4 (19) 
iMLSB phenotype 29 (44.6) 11 (30.5)  0  0 (0) 
TMP-SMX susceptibility 65 (100) 36 (100)  1  21 (100) 
 
 
 
Table 3.  Outcome of the children with CA-MRSA invasive infections treated at the HP-CHPR between 2003 and 2006 and 
microbiological characteristics of their isolates 
   Children with CA-MRSA invasive infections (n = 65) 
 
 
 Admitted to ICU (n = 23)  
Not admitted  to ICU (n = 42) 
Nº (% ) of children with 
isolates carrying the lukS-F genes 
  
19 (82.6) 
 
38 (83.3) 
Nº (% ) of children with 
isolates carrying the cna gene 
  
19 (82.6) 
 
36 (85.7) 
Nº (%) of children with 
isolates belonging to pulsotipo A (USA1100) 
  
19 (82.6) 
 
33 (78.5) 
 
Deaths 
  
8 (34.7) 
 
0 (0) 
 
a One isolate carried SCCmec cassette type I and the other two isolates carried SCCmec cassette type III; b Not applicable 
 
 
Pardo et al. – CA-MRSA infections in Uruguayan children                            J Infect Dev Ctries 2013; 7(1):010-016. 
14 
 
out of 36 isolates carried lukS-F genes; 29 isolates 
carried the cna gene; and 29 isolates belonged 
pulsotype A (USA1100) (Table 2). 
Using the Fisher’s exact test, no significant 
association was found between clinical outcome (death 
or recovery and invasive disease; n = 89) and the 
presence or absence of lukS-F and cna genes (P = 
0.428 and P = 0.712, respectively). 
 
Discussion 
We analyzed all the invasive S. aureus infections 
diagnosed at the HP-CHPR over a three-year period. 
CA-MRSA isolates accounted for 73% (65/89) of 
these infections and the case fatality rate (34.7 %) was 
similar to that previously reported [19-21]. CA-MRSA 
isolates produced a wide spectrum of invasive 
diseases; however, MSSA isolates were mainly 
responsible for bacteraemia and osteoarticular 
infections. The proportion of bone and joint infections 
and of bacteraemias caused by CA-MRSA was similar 
(66% and 67%, respectively), while the 95% (19/20) 
of pneumonia cases was due to CA-MRSA isolates. 
The emergence of CA-MRSA in Uruguay has 
created concern regarding appropriate empirical 
antimicrobial therapy [7,8,22-24]. TMP-SMX and CLI 
have been used to treat uncomplicated SSTIs and mild 
invasive infections in the HP-CHPR since 2001, 
whereas vancomycin is reserved for life-threatening 
cases. However, the first two antibiotics have some 
limitations; for example, trimethoprim- 
 
sulfamethoxazol has no activity against group A 
streptococci which are sometimes involved in SSTI. 
Another concern is the presence of TMP-SMX 
resistant CA-MRSA isolates. Fortunately, we did not 
detect any resistance to TMP-SMX; nevertheless, a 
resistance rate of 97% to TMP-SMX in CA-MRSA 
isolates (agr type III, ST88, SCCmec IV and PVL 
positive) recovered from children was reported in 
Nigeria [25]. This group suggested that the prevalence 
of TMP-SMX resistance could be due to widespread 
and indiscriminate use of this antimicrobial 
combination in areas with populations of low socio-
economic status and overcrowding, factors that 
increase the risk of microbial spreading of these strains 
[25]. Similar findings were reported recently in Tehran 
[26]. This situation may also occur in Uruguay 
because several of the clinical conditions are also 
present. It is important to maintain an active 
surveillance for CA-MRSA susceptibility patterns to 
permit early detection of changes that will affect 
therapeutic treatment. 
Clindamycin remains a mainstay of therapy for 
CA-MRSA infections. However, we must take into 
account that isolates exhibiting the iMLSB phenotype 
have a high rate of spontaneous mutation that could 
lead to constitutive resistance; these isolates could be 
selected by the use of clindamycin [27-29]. In this 
study of 101 CA-MRSA isolates, 40 showed the 
iMLSB phenotype (Table 2). However, the prevalence 
of the iMLSB phenotype decreased over time (Figure 
2) despite the increased use of clindamycin during the 
Figure 2. Evolution of the iMLSB phenotype in CA-MRSA 
isolates recovered from children treated at the HP-CHPR 
between 2003 and 2006 
 
Figure 3. PFGE pulsotype distribution of CA-MRSA isolates 
recovered from children treated at the HP-CHPR between 
2003 and 2006   
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study period in the HP-CHPR [30]. A similar 
observation was previously reported by other authors 
and might represent an expansion of a better adapted 
CA-MRSA clone lacking erm genes as previously 
suggested [31]. 
In a previous study which included CA-MRSA 
strains isolated between December 2004 and 
November 2005 from adults living in different regions 
of Uruguay, we found a CA-MRSA isolate designated 
as group 1 (pulsotype A- USA1100-, SCCmec IV, 
PVL positive, CP 8 and iMLSB negative) responsible 
for most cases of SSTI [8]. The spread and 
establishment of CA-MRSA isolates belonging to 
group 1 could also account for the situation in the 
paediatric population. Supporting this hypothesis, we 
noted that the decrease in the relative frequency of 
CA-MRSA isolates with iMLSB phenotype during this 
study occurred along with a relative increase in the 
proportion of CA-MRSA isolates belonging to the 
pulsotype A (PFGE profile type USA1100) (Figure 3). 
Six of 21 MSSA invasive isolates showed a 
positive result for PVL by PCR (Table 2). Although 
our sample is small, the frequency of the lukS-F genes 
seems relatively higher than that reported in other 
studies [12,32] but similar to the frequency reported 
by Perez-Vazquez et al. in Spain [33]. We identified a 
predominant pulsotype in MSSA invasive isolates, 
similar to the situation observed with CA-MRSA 
isolates, even though the overall diversity observed 
within MSSA isolates was greater. 
Regarding the outcome of children with CA-
MRSA invasive diseases, we observed a rate of 
admissions to ICU (35.4%) and a mortality figure 
(34.7%) similar to that previously reported in the USA 
[21] but higher than that found in children from 
Tunisia [34]. However, these CA-MRSA isolates 
displayed microbiological characteristics similar to 
those recovered from children with invasive infections 
and better clinical outcome (Table 3).  Further 
research on CA-MRSA pathogenesis is necessary to 
determine the role host factors (e.g., deficit in the 
generation of an oxidative burst and production of 
reactive oxygen species with bactericidal activity by 
polymorphonuclear leukocytes), other bacterial 
virulence traits such as enzymes and other proteins 
encoded in the arginine catabolic mobile element 
(ACME), as well as the level of gene expression of 
known virulence factors play in directing the 
differential outcome of these host-pathogen 
interactions. 
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